H-P Schmid
Hypertriglyceridemia as a possible risk factor for prostate cancer
Wuermli L, Jörger M, Henz S, Schmid H, Riesen W, Thomas G, Krek W, Cerny T, Gillessen Sommer S. Hypertriglyceridemia as a possible risk factor for prostate cancer. Prostate cancer and prostatic diseases 2005; 8:316-20.
Jan 1, 2005Hypertriglyceridemia as a possible risk factor for prostate cancer
Jan 1, 2005Prostate cancer and prostatic diseases 2005; 8:316-20
Wuermli L, Jörger Markus, Henz Samuel, Schmid H-P, Riesen W F, Thomas G, Krek W, Cerny Thomas, Gillessen Sommer Silke
[Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens]
Prikler L, Scandella E, Men Y, Engeler D, Diener P, Gillessen Sommer S, Ludewig B, Schmid H. [Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens]. Aktuelle Urologie 2004; 35:326-30.
Aug 1, 2004[Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens]
Aug 1, 2004Aktuelle Urologie 2004; 35:326-30
Prikler L, Scandella Elke, Men Y, Engeler Daniel, Diener P-A, Gillessen Sommer Silke, Ludewig Burkhard, Schmid H-P
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial
Morant R, Hering F, Hanselmann S, Gschwend A, Wernli M, Cerny T, Rochlitz C, Bauer J, Borner M, Bonomo M, Gillessen Sommer S, Dietrich D, Bernhard J, Schmid H. Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial. British journal of cancer 2004; 90:1312-7.
Apr 5, 2004Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial
Apr 5, 2004British journal of cancer 2004; 90:1312-7
Morant R, Hering F, Hanselmann S, Gschwend A, Wernli M, Cerny Thomas, Rochlitz C, Bauer J, Borner M, Bonomo M, Gillessen Sommer Silke, Dietrich D, Bernhard J, Schmid H-P
Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer
Jörger M, Warzinek T, Klaeser B, Kluckert J, Schmid H, Gillessen Sommer S. Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 2004; 63:778-80.
Apr 1, 2004Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer
Apr 1, 2004Urology 2004; 63:778-80
Jörger Markus, Warzinek T, Klaeser B, Kluckert J T, Schmid H-P, Gillessen Sommer Silke
Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study
Morant R, Hering F, Bauer J, Hanselmann S, Jacky E, Streit A, Forrer P, Egli F, Wernli M, Borner M, Thürlimann B, Bernhard J, Hsu Schmitz S, Schmid H. Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study. European journal of cancer (Oxford, England : 1990) 2002; 38:1626-32.
Aug 1, 2002Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study
Aug 1, 2002European journal of cancer (Oxford, England : 1990) 2002; 38:1626-32
Morant R, Hering F, Bauer J, Hanselmann S, Jacky E, Streit A, Forrer P, Egli F, Wernli M, Borner M, Thürlimann Beat, Bernhard J, Hsu Schmitz S-F, Schmid H-P